PRKN and cholangiocarcinoma: For example, the overexpression of miR-181b-5p enhanced cholangiocarcinoma cell invasion, migration, and proliferation by regulating PARK2 via the PTEN/PI3K/AKT signaling pathway (Jiang et al., 2022).